Apollo Endosurgery (APEN) Catalyst Opens the Door to Reimbursement for Orbera - Craig-Hallum
Tweet Send to a Friend
Craig-Hallum analyst Matthew Hewitt reiterated a Buy rating and $11.00 price target on Apollo Endosurgery (NASDAQ: APEN) after a CPT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
